In this real-world study of patients with type 2 diabetes, treatment with semaglutide resulted in greater reductions in body weight and hemoglobin A1c than dulaglutide.
Emily Thomas, PharmD, BCPS, BCACP
Advertisement
Articles by Emily Thomas, PharmD, BCPS, BCACP
The authors studied the impact of a pharmacist intervention on blood pressure control compared with usual care.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Emerging Data Suggest Survodutide Targets Liver Fat More Rapidly Than Weight Loss: Lee Kaplan, MD, PhD
2
Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention
3
Social Factors Shape Diabetes, Dementia Risk Across Populations
4
INHALE-1 Findings Support Inhaled Insulin as a Viable Option for Pediatric Patients: Kevin Kaiserman, MD
5